Sandeep Samethadka Nayak

Dr. Sandeep Samethadka Nayak


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SNSandeep Samethadka Nayak
Sandeep Samethadka Nayak
SHSeyyed Mohammad Hashemi
Seyyed Mohammad Hashemi
MPMasum Patel
Masum Patel
NSNimra Shafi
Nimra Shafi
PBPubali Biswas
Pubali Biswas
KAKwame Boateng Agyeman
Kwame Boateng Agyeman
Background: This study explores how weight loss impacts thyroid hormone levels, particularly free T3 (FT3) and FT4, in obese individuals, given the key role these hormones play in regulating metabolism and gene expression. Methods: A comprehensive literature search in PubMed, ISI/Web of Science, and Scopus databases identified studies examining the correlation between weight, body mass index (BMI), and thyroid hormone levels. Results: The analysis revealed that BMI reduction significantly decreases FT3 levels [odds ratio (OR) = 2.31, 95% confidence interval (CI): 1.73–3.10, P < 0.01] and increases FT4 levels (OR = 0.68, 95% CI: 0.47–0.98, P = 0.04). Weight loss results in a significant reduction in FT3 (OR = 2.47, 95% CI: 1.68–3.64, P < 0.01) and thyroid-stimulating hormone (TSH) (OR = 1.76, 95% CI: 1.15–2.69, P < 0.01), as well as a significant increase in FT4 (OR = 0.69, 95% CI: 0.55–0.88, P < 0.01). Subgroup analysis indicated that changes in thyroid hormone levels were more pronounced in obese individuals who underwent diet calorie restriction compared to bariatric surgery. Conclusion: The study results indicate that weight reduction leads to a decrease in TSH and FT3 levels and an increase in FT4 levels. Calorie restriction through diet has a more pronounced effect on thyroid function compared to bariatric surgery. Clinicians should approach elevated TSH levels in obese patients with caution, emphasizing weight management strategies as the primary therapeutic intervention before resorting to pharmacological treatments.

8 July 2024 in JMIR Medical Education
Verified
Journal Article
Open access
SHSoheil Hassanipour
Soheil Hassanipour
SNSandeep Samethadka Nayak
Sandeep Samethadka Nayak
ABAli Bozorgi
Ali Bozorgi
MKMohammad-Hossein Keivanlou
Mohammad-Hossein Keivanlou
TDTirth Dave
Tirth Dave
EAEhsan Amini-Salehi
Ehsan Amini-Salehi
Background: The introduction of ChatGPT by OpenAI has garnered significant attention. Among its capabilities, paraphrasing stands out. Objective: This study aims to investigate the satisfactory levels of plagiarism in the paraphrased text produced by this chatbot. Methods: Three texts of varying lengths were presented to ChatGPT. ChatGPT was then instructed to paraphrase the provided texts using five different prompts. In the subsequent stage of the study, the texts were divided into separate paragraphs, and ChatGPT was requested to paraphrase each paragraph individually. Lastly, in the third stage, ChatGPT was asked to paraphrase the texts it had previously generated. Results: The average plagiarism rate in the texts generated by ChatGPT was 45% (SD 10%). ChatGPT exhibited a substantial reduction in plagiarism for the provided texts (mean difference −0.51, 95% CI −0.54 to −0.48; P<.001). Furthermore, when comparing the second attempt with the initial attempt, a significant decrease in the plagiarism rate was observed (mean difference −0.06, 95% CI −0.08 to −0.03; P<.001). The number of paragraphs in the texts demonstrated a noteworthy association with the percentage of plagiarism, with texts consisting of a single paragraph exhibiting the lowest plagiarism rate (P<.001). Conclusion: Although ChatGPT demonstrates a notable reduction of plagiarism within texts, the existing levels of plagiarism remain relatively high. This underscores a crucial caution for researchers when incorporating this chatbot into their work.

6 September 2024 in International Journal of Surgery
Verified
Journal Article
Open access
SNSandeep Samethadka Nayak
Sandeep Samethadka Nayak
EAEhsan Amini-Salehi
Ehsan Amini-Salehi
FJFarahnaz Joukar
Farahnaz Joukar
PBPubali Biswas
Pubali Biswas
SNSara Nobakht
Sara Nobakht
MKMohammad-Hossein Keivanlou
Mohammad-Hossein Keivanlou
Background: Primary aldosteronism (PA) is now recognized as the most prevalent form of secondary hypertension globally, contributing significantly to cardiovascular morbidity and mortality. This umbrella review aims to systematically compare cardiovascular outcomes and all-cause mortality in PA patients undergoing adrenalectomy versus mineralocorticoid receptor antagonist (MRA) treatment, aiming to inform optimal management strategies. Method: Following PRISMA guidelines, Supplemental Digital Content 1, https://links.lww.com/JS9/D386 , Supplemental Digital Content 2, https://links.lww.com/JS9/D387 , a comprehensive search strategy was employed across multiple databases. Meta-analyses focusing on cardiovascular outcomes or all-cause mortality, comparing adrenalectomy and MRAs treatment in PA patients, were included. Studies were independently screened and assessed for quality using AMSTAR 2, Supplemental Digital Content 3, https://links.lww.com/JS9/D388 and GRADE checklists. Results: A total of 8 studies met the inclusion criteria. Adrenalectomy showed potential benefits over MRAs in reducing the risk of arrhythmias (OR=2.17; 95% CI: 1.25-3.76) and major adverse cardiovascular events (OR=1.81; 95% CI: 1.33-2.46). Patients treated with MRAs exhibited a higher risk of cardiovascular events (OR=1.23; 95% CI: 1.05-1.44), hypertension (OR=3.22; 95% CI: 1.15-8.97), and all-cause mortality (OR=3.03; 95% CI: 1.36-6.70) compared to adrenalectomy. Conclusion: Adrenalectomy appears to offer favorable outcomes compared to MRAs treatment in PA patients, particularly in reducing the risk of major adverse cardiovascular events and all-cause mortality. These findings suggest the importance of considering surgical intervention as a primary treatment modality for PA. Export

16 May 2022 in Heart & Lung
Verified
Journal Article
Closed access
SNSandeep Samethadka Nayak
Sandeep Samethadka Nayak
RBRachana Borkar
Rachana Borkar
SGSherief Ghozy
Sherief Ghozy
KAKwame Agyeman
Kwame Agyeman
MAMohammed T. Al-Juboori
Mohammed T. Al-Juboori
MUMichael T. Ulrich
Michael T. Ulrich

25 January 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
EAEhsan Amini-Salehi
Ehsan Amini-Salehi
SNSandeep Samethadka Nayak
Sandeep Samethadka Nayak
GMGautam Maddineni
Gautam Maddineni
AMAbinash Mahapatro
Abinash Mahapatro
MKMohammad-Hossein Keivanlou
Mohammad-Hossein Keivanlou
SHSoheil Hassanipour
Soheil Hassanipour
Background and aim: Modulating the gut microbiota population by administration of probiotics, prebiotics, and synbiotics has shown to have a variety of health benefits in different populations, particularly those with metabolic disorders. Although the promising effects of these compounds have been observed in the management of patients with non-alcoholic fatty liver disease (NAFLD), the exact effects and the mechanisms of action are yet to be understood. In the present study, we aimed to evaluate how gut microbiota modulation affects anthropometric indices of NAFLD patients to achieve a comprehensive summary of current evidence-based knowledge. Methods: Two researchers independently searched international databases, including PubMed, Scopus, and Web of Science, from inception to June 2023. Meta-analysis studies that evaluated the effects of probiotics, prebiotics, and synbiotics on patients with NAFLD were entered into our umbrella review. The data regarding anthropometric indices, including body mass index, weight, waist circumference (WC), and waist-to-hip ratio (WHR), were extracted by the investigators. The authors used random effect model for conducting the meta-analysis. Subgroup analysis and sensitivity analysis were also performed. Results: A total number of 13 studies were finally included in our study. Based on the final results, BMI was significantly decreased in NAFLD patients by modulation of gut microbiota [effect size (ES): −0.18, 05% CI: −0.25, −0.11, P<0.001]; however, no significant alteration was observed in weight and WC (ES: −1.72, 05% CI: −3.48, 0.03, P=0.055, and ES: −0.24, 05% CI: −0.75, 0.26, P=0.353, respectively). The results of subgroup analysis showed probiotics had the most substantial effect on decreasing BMI (ES: −0.77, 95% CI: −1.16, −0.38, P<0.001) followed by prebiotics (ES: −0.51, 95% CI: −0.76, −0.27, P<0.001) and synbiotics (ES: -0.12, 95% CI: −0.20, −0.04, P=0.001). Conclusion: In conclusion, the present umbrella meta-analysis showed that although modulation of gut microbiota by administration of probiotics, prebiotics, and synbiotics had promising effects on BMI, no significant change was observed in the WC and weight of the patients. No sufficient data were available for other anthropometric indices including waist-to-hip ratio and waist-to-height ratio and future meta-analyses should be done in this regard.

5 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
AMArian Mirdamadi
Arian Mirdamadi
MJMona Javid
Mona Javid
EAEhsan Amini-Salehi
Ehsan Amini-Salehi
FMFatemeh Mohammadyari
Fatemeh Mohammadyari
STShervin Tavakoli
Shervin Tavakoli
SHSoheil Hassanipour
Soheil Hassanipour
Background: Laparoscopic appendectomy (LA) is a standard treatment for acute appendicitis (AA), offering reduced complications and improved patient outcomes. However, in certain cases, the need for conversion to open appendectomy (OA) may arise. The present systematic review and meta-analysis aimed to identify preoperative risk factors associated with conversion from LA to OA. Method: The global databases of PubMed, Web of Science, Scopus, and Embase were systematically searched from inception to 20 April 2024. Studies evaluating clinical, laboratory, and imaging risk factors of conversion from LA to OA were assessed for inclusion eligibility. Fixed-effects or random-effects models were utilized to calculate pooled odds ratio (OR) and standard difference in mean (SMD) with a 95% confidence interval (CI), using Comprehensive Meta-Analysis software version 3. The Joanna Briggs Institute Critical Appraisal Checklist was employed to assess the quality of the eligible studies. Results: In total, 45 studies with an overall sample size of 3,202,336 were included for meta-analysis. The conversion rate from LA to OA was 8.7% (95% CI: 7.7%, 9.8%). Conversion was associated with older age, male gender, and comorbidities such as obesity, diabetes, hypertension, and cardiovascular disease. Previous abdominal surgery, prolonged symptom duration, higher Alvarado score, elevated inflammatory markers, and imaging findings (e.g., larger appendiceal diameter and intra-abdominal fluid) were also significant predictors. Conclusion: The present systematic review and meta-analysis identified the most important clinical, laboratory, and imaging factors associated with the conversion from LA to OA, aiding surgeons in perioperative risk stratification and improving patient outcomes. Despite the inclusion of high-quality studies, the majority were retrospective, and the quality of evidence for many risk factors was moderate to low, representing an important limitation. Graphical Graphical abstract presented here http://links.lww.com/JS9/E650.